Business Wire

FDA Grants DeNovo Clearance to Atlantic Therapeutics for INNOVO® Therapy Device to Treat Stress Urinary Incontinence

Jaa

Atlantic Therapeutics, a global manufacturer of innovative, garment-based pelvic floor muscle strengthening and nerve stimulation products, announced today (13.11.18) that the U.S. Food and Drug Administration (FDA) has granted a DeNovo clearance for its INNOVO® therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence in adult females.

FDA Approval Supported by Results from Two Multi-Centre Randomized Controlled Clinical Trials

INNOVO® is the first transcutaneous electrical stimulation continence device to be cleared by the FDA, following results of two randomized controlled trials (RCTs) demonstrating it to be an effective and low-risk device for the treatment for stress urinary incontinence (SUI) in adult females. Atlantic Therapeutics presented key data from its pivotal US trial showing 87.2% of patients were dry or mild of after a 12-week treatment period1, with 93% of patients experiencing improvement in just 4 weeks1. This follows the presentation of data from an earlier sham-controlled RCT conducted in Europe that demonstrated significant improvement across all study endpoints2.

“For the first time, physicians in the U.S. can offer their patients a safe, clinically effective, non-invasive home-based treatment,” said Steve Atkinson, CEO, Atlantic Therapeutics.

“INNOVO® therapy is a compelling treatment option for all those women who today simply suffer in silence from stress urinary incontinence.”

With an estimated one third of all U.S. females affected by SUI3, the market potential for INNOVO® is significant, making this big news for the Galway, Ireland, based medical device manufacturer. With recent widespread reports of mesh surgery complications, this is an ideal time to offer a non-invasive option. INNOVO® has an excellent safety record to date, with over 1.5 million therapy sessions delivered by INNOVO® in Europe and no reported device related complications.

"INNOVO® is a major breakthrough for the millions of women who have to deal with the emotional and physical daily burden of incontinence,” said Gordie Nye, Chairman of Atlantic Therapeutics, “INNOVO® is the active solution for U.S. women who otherwise face a life wearing absorbent pads.”

Mary Lynne Van Poelgeest-Pomfret, President of the World Federation of Incontinence Patients (WFIP) said, “WFIP is excited to hear that INNOVO® has received FDA clearance, enhancing treatment choice for U.S. patients. We are confident it will change people’s lives; INNOVO® therapy is fully supported by the WFIP."

INNOVO® has been well received by many U.S. organisations and healthcare professionals concerned with the welfare of patients with incontinence.

“INNOVO® offers a new frontline therapeutic option for the millions of American women living with stress urinary incontinence, and in a significant group could delay or prevent the need for higher risk surgery or medical intervention,” said Elizabeth LaGro, Vice President, The Simon Foundation for Continence.

ENDS

References

1. ICS 2018, POSTER NO. 235, Roger Dmochowski, Vanderbilt University, Catherine M. Lynch, University of South Florida, Mitchell Efros, AccuMed Research Associates, Linda Cardozo, King’s College Hospital, London.

2. IUGA 2018, Poster NO. 135, S.Soeder, German pelvic Floor Center Berlin, T. Fink, Pelvic floor Center, Berlin–Lichtenberg, M. Goetze, Hospital Brandenburg, G. Neymeyer, Charite Medical University, Berlin R.Tunn German pelvic Floor Center Berlin

3. The Urology Care Foundation (2018) Available at: [http://www.urologyhealth.org/] (Accessed: 24th August 2018)

About Atlantic Therapeutics

Atlantic Therapeutics develops professional and consumer medical devices, related software, apps and connected health technologies to treat all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor. INNOVO® from Atlantic Therapeutics is a unique, externally applied, patented CE device that delivers a safe, clinically effective and comfortable therapy to treat reversible clinical conditions associated with pelvic floor weakness in the comfort of the user’s own home. Learn more at: www.restorethefloor.com

Contact information

Media enquiries
ROAD Communications
Paul Jarman
paul@roadcommunications.co.uk
+44 (0) 208 995 5832
or
US enquiries
Atlantic Therapeutics
Ruta Johnson
rjohnson@atlantictherapeutics.com
+1 (925) 5195930

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

L’Oréal Rewards Social Initiatives Led by Dermatologists at World Congress of Dermatology in Milan20.6.2019 12:23:00 EESTTiedote

In partnership with the International League of Dermatological Societies (ILDS) and the 24th World Congress of Dermatology (WCD), L’Oréal announced the laureates of the third International Awards for Social Responsibility in Dermatology: “Caring to Inspire Skin Confidence”. This aims to reward social initiatives led by dermatologists, improving patients’ physical and psychological well-being, self-esteem, social integration and skin health, and enabling patients to re-engage socially. Brigitte Liberman, President of L’Oréal’s Active Cosmetics Division, said: “Social responsibility is a priority for L’Oréal and we are proud to partner with the ILDS and the WCD to reward iconic dermatologists having positive actions on people’s lives”. Professor Harvey Lui, President of the ILDS, added: “Beyond the day-to-day activities of dermatologists in managing patients with skin issues, there is a vital social role, which is exemplified through our partnership for these awards and lies at the heart

First deployment of open-standard Identity Management interface OSIA in DRC20.6.2019 11:45:00 EESTTiedote

IDEMIA, the global leader in Augmented Identity, in partnership with CIVIPOL, the technical cooperation operator of the French Ministry of the Interior, DIGITECH, a leading provider of paperless Civil Registry solutions, UNFPA, the United Nations Population Fund and CARITAS, a confederation of 165 Catholic relief, development and social service organizations, announces the first deployment of the open-standard Identity Management interface OSIA in the Democratic Republic of Congo (DRC). This World Bank funded project aims to register 2.4 million children and produce 600,000 birth certificates. The consortium led by CIVIPOL supports the ambitious goal set out by the United Nations General Assembly “One ID for all by 2030.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190620005047/en/ Credits : IDEMIA The consortium focusses on two project streams: the first stream concentrates on the enhancement of the current Civil Registr

Wrap.co Releases The World’s First SaaS Software in Historic Global Announcement20.6.2019 08:00:00 EESTTiedote

Wrap.co, The Mobile Card-Based Innovator™, released The World’s First SaaS Software today—highlighting the ease by which their card-based mobile engagement and conversion platform conveys complex ideas quickly to a global audience poised to consume content at “The Speed of Thumb™”. “According to Danny Hillis in his book, The Pattern on The Stone, any series of yes/no decisions can be considered software—thus,” said Christopher Bruno, CEO of Wrap.co, “we chose pre-historic Irish engravings—ancient when the Pyramids were built—to illustrate how Wrap can allow a mobile user unacquainted with a technical topic to flip through selected content to arrive at hoped-for conclusion in mere seconds—in this case: the belief that an animated engraving represents the 19-year cycle of the moon.” Bruno chose the so-called “Calendar Stone of Knowth” in County Meath, Ireland, as the subject matter for their first global presentation of Wrap.co’s revolutionary carrier-grade card-based communication platf

Algorand Foundation Marks New Chapter in Global Economics with Inaugural Auction19.6.2019 23:56:00 EESTTiedote

The Algorand Foundation announced today the successful completion of its inaugural Algo auction, marking the launch of the Algorand platform and its original economic model that uses a unique combination of consensus-driven blockchain technology and economic incentives to ensure absolute fairness and broad participation in a new Borderless Economy. The auction brings Algos, the native token of the Algorand blockchain platform, into market circulation for the first time. Originally scheduled to last for more than five hours, the auction sold out in under four hours, due to oversubscribed demand from a large group of global participants. The Dutch Auction mechanism ensured the market, not the seller, set the price of the offering and that each participant paid the same price per Algo. The Algorand platform is the first public, permissionless pure proof-of-stake blockchain protocol that solves the “blockchain trilemma” of achieving scalability, security and true decentralization all at on

Cooper & Turner Announces Potential Combination with Beck Industries19.6.2019 22:32:00 EESTTiedote

Andaray (Holdings) Limited and its direct and indirect subsidiaries (“Cooper & Turner”) have entered into an agreement with Beck Industries (“Beck”) for potential combination of the two groups. The contemplated combined entity aims to be the first truly global manufacturer of safety critical fasteners, together supporting a broader range of industries – including renewable energy, tunneling, construction, rail, heavy equipment, downstream oil & gas, power generation and nuclear, among others. Headquartered in Sheffield, England, Cooper & Turner serves a global customer base with manufacturing and distribution operations across the European Union, China and North America. This worldwide network enables Cooper & Turner to offer a seamless, one-stop shop solution for industrial fasteners that meet the highest levels of quality. Beck, a France-based manufacturer and distributor of fully certified, high-security bolting components, has built a global operation that complements and expands t

Tinubu Square Appoints Sophie Riottot as Group Sales Director19.6.2019 20:02:00 EESTTiedote

Tinubu Square, a leading provider of credit insurance, surety and trade finance solutions, has announced the appointment of Sophie Riottot as Group Sales Director. This is a strategic engagement for the company, which is restructuring its sales approach to reinforce its rapid global growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190619005634/en/ Sophie Riottot, new Group Sales Director at Tinubu Square (Photo: Business Wire) Sophie Riottot brings a wealth of experience to Tinubu Square. She joins the company from Dhatim, a French start-up specializing in AI-powered invoice services, where she was responsible for sales strategy and partnership development. Prior to this, she was with Microsoft for over 17 years, in a variety of prominent sales and management positions, including Head of Finance in the Services Division. As a member of the executive committee at Tinubu Square, Sophie will be responsible for spearheadin

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme